The global insulin pump market size is estimated to reach USD 9.66 billion by 2030, registering to grow at a CAGR of 8.42% from 2025 to 2030 according to a new report by Grand View Research, Inc. The key factors driving the growth of the market are the technological advancements and the adoption of pumps over traditional methods. These pumps are very convenient for people who require daily multiple injections of insulin.

Insulin pump is a machine that enables insulin to be delivered either manually or automatically. These pumps can be programmed to deliver a specific set of doses and can also deliver a larger set of doses of glucose whenever required, such as before a meal. Patients can connect these devices to their smartphones to calibrate blood glucose readings. Technological advancement and new product launches across the globe are also fueling the market during the forecast period. For instance, Medtronic’s MiniMed 670G system is the world’s first hybrid closed loop system that acts as an artificial pancreas. The system provides automated insulin delivery as per the patient’s CGM readings.

The insulin pumps market is anticipated to witness a high growth rate during the forecast period due to the continuous efforts for diabetes control by government and healthcare organizations such as the International Diabetes Federation (IDF). These organizations provide required expertise and support diabetes awareness campaigns through a network of stakeholders and partners. Also, increasing health care funding is anticipated to propel growth. Additionally, the market is expected to witness a shift from the usage of traditional tethered pumps to patch pumps driven by their compact size and ease of use.

Insulin Pump Market Report Highlights

• The tethered pumps segment dominated the market in 2024 and expected to lead during the forecast period. Tethered insulin pumps are connected to the body via a small tube linked to a cannula.
• The MiniMed segment dominated the market with a share of 52.9% in 2024. the high adoption rate and technological advancement.
• The insulin set insertion devices segment dominated the market with a share of 41.4% in 2024. The insulin set insertion market high share is attributed to notable growth due to advancements in user-friendly designs and enhanced comfort.
• The hospital segment dominated the market with a share of over 44.4 % in 2024. Hospitals are increasingly adopting advanced diabetes management technologies, including insulin pumps, to improve patient outcomes.

Insulin Pump Market Segmentation

Grand View Research has segmented the global insulin pump market based on type, product, accessories, end-use and region:

Insulin Pump Type Outlook (Revenue, USD Million, 2018 - 2030)

• Patch pumps
• Tethered pumps

Insulin Pump Product Outlook (Revenue, USD Million, 2018 - 2030)

• MiniMed
• Accu-Chek
• Tandem
• Omnipod
• My life omnipod
• Others

Insulin Pump Accessories Outlook (Revenue, USD Million, 2018 - 2030)

• Insulin reservoir or cartridges
• Insulin set insertion devices
• Battery           

Insulin Pump End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals & clinics
• Homecare
• Laboratories

Insulin Pump Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
  • Mexico
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Key Players in the Insulin Pump Market

• Medtronic
• Hoffmann-La Roche AG
• Tandem Diabetes Care, Inc.
• Insulet Corporation
• Ypsomed
• Sanofi S.A.
• Sooil development
• Jiangsu Delfu Co., Ltd.
• Cellnovo Ltd
• Valeritas, Inc

Order a free sample PDF of the Insulin Pump Market Intelligence Study, published by Grand View Research.